-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
DURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reissued a “neutral” rating on shares of DURECT in a research note on Thursday, November 14th. Get Our Latest […]
Stock analysts at StockNews.com assumed coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reissued a “neutral” rating on shares of DURECT in a research note on Thursday, November 14th. Get Our Latest […]
